StockWatch
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultApr 29, 2026, 09:08 AM

AVTR Q1 Net Income $43.3M, -32.9%; EPS $0.06, -33.3%

AI Summary

Avantor, Inc. reported flat net sales of $1,581.4 million for Q1 2026 compared to the prior year. Net income significantly decreased by 32.9% to $43.3 million, with diluted EPS falling to $0.06 from $0.09. The company also noted a sustained decline in its share price, triggering a goodwill impairment assessment, though no impairment was recorded this quarter, with a warning of potential future impairment.

Key Highlights

  • Net sales remained flat at $1,581.4 million for Q1 2026.
  • Net income decreased 32.9% to $43.3 million in Q1 2026 from $64.5 million.
  • Diluted EPS fell 33.3% to $0.06 in Q1 2026 from $0.09.
  • Cash flow from operating activities decreased 46.3% to $58.7 million.
  • Bioscience & Medtech Products net sales increased 1.2% to $431.4 million.
  • VWR Distribution & Services net sales decreased 0.4% to $1,150.0 million.
  • Total debt, gross, was $3,835.9 million as of March 31, 2026.
  • Prepaid $102.4 million on Euro term loans B-6 during the quarter.